Product Description
Product details
- Country of Origin : Made in India
- Form : Tablet
- Packaging Size : 30 Tablets
- Prescription/Non prescription : Prescription
- Treatment : HIV
- Composition : Emtricitabine (200mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)
Comprehensive HIV-1 TreatmentTrustiva provides a powerful antiretroviral therapy (ART) for adults and adolescents diagnosed with HIV-1. Its fixed-dose formulation delivers three active ingredients designed to target the virus at multiple stages, improving the effectiveness of treatment and helping patients manage their condition with a single daily tablet.
Safe and Compliant ManufacturingManufactured under stringent standards by Hetero Healthcare Limited in India, Trustiva is WHO GMP certified, ensuring that each batch meets global quality and safety requirements. The medication is packaged in secure bottles, with a shelf life of 24 months, maintaining therapeutic efficacy for the duration of its use.
Usage and Dosage GuidelinesTrustiva must be taken orally once a day, exactly as prescribed by a healthcare professional. Consistency in dosing is vital for maximizing treatment benefits and minimizing the risk of developing resistance. Patients are advised to follow storage instructions and inform their physician of any concurrent medications to prevent interactions.
FAQ's of Trustiva Tablets Prescription Treatment Hiv:
Q: How should I take Trustiva Tablets for HIV treatment?
A: Trustiva Tablets are to be taken orally, once daily, at the dose prescribed by your physician. Swallow the tablet whole with water, preferably at the same time each day to maintain an even level of medication in your blood.
Q: What are the main benefits of using Trustiva for HIV-1 infection?
A: Trustiva combines three potent antiretroviral agents in a single tablet, simplifying adherence and effectively suppressing HIV-1 replication. This can lead to improved viral control and help maintain immune system health in adults and adolescents.
Q: When can I expect to see results from Trustiva therapy?
A: The response to Trustiva varies among individuals. Typically, improvement in viral load and immune markers is monitored over several weeks to months. Your healthcare provider will schedule regular tests to assess your treatment progress.
Q: What should I do if I miss a dose of Trustiva?
A: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one and continue with your regular schedule. Do not take two doses at once. Missing doses can decrease the effectiveness of therapy.
Q: Are there potential drug interactions with Trustiva?
A: Yes, Trustiva can interact with other antiretroviral and non-antiretroviral drugs. Always inform your doctor about all the medications and supplements you are taking to avoid adverse interactions and adjust dosages if necessary.
Q: Is Trustiva suitable for all patients diagnosed with HIV?
A: Trustiva is recommended for HIV-positive adults and adolescents only. It is not approved for use in children under 18 years of age and may not be suitable for individuals with certain medical conditions or who are taking particular medications.
Q: What are common side effects of Trustiva?
A: Some patients may experience headache, dizziness, nausea, or rash. If these become severe or if you notice any other unusual symptoms, contact your healthcare provider. Your doctor will help assess the risk and manage any side effects appropriately.